Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Bioton S.A.

Headquarters: Macierzysz, Poland
Year Founded: 1989
Status: Public
Industry Sector: HealthTechnology
CEO: Jeremy Launders
Number Of Employees: N/A
Enterprise Value: $72,547,939
PE Ratio: -20.18
Exchange/Ticker 1: Warsaw:BIO
Exchange/Ticker 2: N/A
Latest Market Cap: $82,910,956

BioCentury | Jun 3, 2013
Clinical News

Somatropin Biopartners regulatory update

BioCentury | Sep 24, 2012
Company News

Bioton, Medipolis deal

BioCentury | Aug 27, 2012
Clinical News

Valtropin somatropin regulatory update

BioCentury | Feb 6, 2012
Company News

Bioton, Actavis deal

BioCentury | Oct 10, 2011
Clinical News

LB03002: Phase III data

BioCentury | Dec 11, 2010
Company News

EMA reviewing somatropin safety

BioCentury | Jul 5, 2010
Finance

2H10 milestones

BioCentury | Jun 15, 2009
Clinical News

SR-rhGH: Phase III data

BioCentury | Jun 12, 2009
Clinical News

LB03002 meets growth hormone deficiency endpoint

Items per page:
1 - 10 of 18